{"text": "We used three indicators (or proxy measures) to identify persons with depressive symptoms.", "sentId": 1, "start": 0, "end": 90}
{"text": "First, participants responded to the self-administered 30-item General Health Questionnaire (GHQ) at phases 3, 5, 7, and 9, a screening instrument designed for and widely used in population-based surveys and trials (26).", "sentId": 2, "start": 91, "end": 311}
{"text": "Each questionnaire item enquires about a specific symptom, with response categories scored as either 1 or 0 to indicate whether the symptom is present.", "sentId": 3, "start": 312, "end": 463}
{"text": "Total score of 5 or more led to individuals being defined as GHQ-symptom cases and scores 0 to 4 as noncases (27).", "sentId": 4, "start": 464, "end": 578}
{"text": "Although the GHQ was originally designed to assess depressive and anxiety symptoms, a recent population-based study showed GHQ caseness to be sensitive (84%) and specific (84%) in detecting dysthymia or major depressive disorder, as indicated by the Composite International Diagnostic Interview (28).", "sentId": 5, "start": 579, "end": 879}
{"text": "The GHQ has also been validated at baseline against a clinical interview schedule in the Whitehall II study, with acceptable sensitivity (73%) and specificity (78%) (27).", "sentId": 6, "start": 880, "end": 1050}
{"text": "In a more recent validation using a subgroup of 274 participants aged 58 to 70 in 2010, the sensitivity and specificity of GHQ symptom caseness against diagnosed depressive episodes based on a structured psychiatric interview were 80% and 81%, respectively.", "sentId": 7, "start": 1051, "end": 1308}
